Please login to the form below

Not currently logged in
Email:
Password:

AZ's Mene Pangalos joins Precision Medicine Catapult board

Has also been appointed a fellow at the University of Cambridge
Mene Pangalos

AstraZeneca's Mene Pangalos, executive VP of IMED Biotech, has been appointed in two new positions based in Cambridge.

Pangalos will join the board of the Precision Medicine Catapult, the newly established centre in Cambridge designed to shape the future of precision medicine in the UK.

In his role as non-executive director, Pangalos will provide a pharmaceutical industry perspective on how to ensure the UK can remain at the cutting edge of precision medicine.

Additionally, Pangalos has also been appointed an as official fellow of Clare Hall College in the University of Cambridge.

Pangalos said: “I'm delighted to receive these two appointments. Although they are a great personal honour, I believe they are testament to the quality of our science, our pioneering approach to personalised healthcare and our long standing commitment to strengthening the UK life science sector.”    

13th November 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics